183 related items for PubMed ID: 33460392
1. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
Bacila I, Freeman N, Daniel E, Sandrk M, Bryce J, Ali SR, Yavas Abali Z, Atapattu N, Bachega TA, Balsamo A, Birkebæk N, Blankenstein O, Bonfig W, Cools M, Costa EC, Darendeliler F, Einaudi S, Elsedfy HH, Finken M, Gevers E, Claahsen-van der Grinten HL, Guran T, Güven A, Hannema SE, Higham CE, Iotova V, van der Kamp HJ, Korbonits M, Krone RE, Lichiardopol C, Luczay A, Mendonca BB, Milenkovic T, Miranda MC, Mohnike K, Neumann U, Ortolano R, Poyrazoglu S, Thankamony A, Tomlinson JW, Vieites A, de Vries L, Ahmed SF, Ross RJ, Krone NP.
Eur J Endocrinol; 2021 Apr; 184(4):553-563. PubMed ID: 33460392
[Abstract] [Full Text] [Related]
2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
3. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 25; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
5. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
Clin Genet; 2012 Jul 25; 82(1):64-70. PubMed ID: 21534945
[Abstract] [Full Text] [Related]
6. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W, Schwarz HP.
Clin Endocrinol (Oxf); 2014 Dec 25; 81(6):871-5. PubMed ID: 24818525
[Abstract] [Full Text] [Related]
7. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Espinosa Reyes TM, Leyva González G, Domínguez Alonso E, Falhammar H.
Horm Res Paediatr; 2021 Dec 25; 94(1-2):1-8. PubMed ID: 34044395
[Abstract] [Full Text] [Related]
8. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Dec 25; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
9. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
Horm Res Paediatr; 2018 Dec 25; 89(1):7-12. PubMed ID: 29073619
[Abstract] [Full Text] [Related]
10. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U, Braune K, Whitaker MJ, Wiegand S, Krude H, Porter J, Digweed D, Voet B, Ross RJM, Blankenstein O.
J Clin Endocrinol Metab; 2021 Mar 08; 106(3):e1433-e1440. PubMed ID: 32888021
[Abstract] [Full Text] [Related]
11. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
Neumann U, van der Linde A, Krone RE, Krone NP, Güven A, Güran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS, Balsamo A, Hannema SE, Birkebaek N, Vieites A, Thankamony A, Cools M, Milenkovic T, Bonfig W, Costa EC, Atapattu N, de Vries L, Guaragna-Filho G, Korbonits M, Mohnike K, Bryce J, Ahmed SF, Voet B, Blankenstein O, Claahsen-van der Grinten HL.
Eur J Endocrinol; 2022 Apr 11; 186(5):587-596. PubMed ID: 35290211
[Abstract] [Full Text] [Related]
12. Salt wasting in simple virilizing congenital adrenal hyperplasia.
Frisch H, Battelino T, Schober E, Baumgartner-Parzer S, Nowotny P, Vierhapper H.
J Pediatr Endocrinol Metab; 2001 Apr 11; 14(9):1649-55. PubMed ID: 11795656
[Abstract] [Full Text] [Related]
13. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2017 Jan 11; 165(Pt B):396-406. PubMed ID: 27544322
[Abstract] [Full Text] [Related]
14. Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.
El-Maouche D, Hargreaves CJ, Sinaii N, Mallappa A, Veeraraghavan P, Merke DP.
J Clin Endocrinol Metab; 2018 Jun 01; 103(6):2336-2345. PubMed ID: 29584889
[Abstract] [Full Text] [Related]
15. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP.
J Clin Endocrinol Metab; 2016 Dec 01; 101(12):4690-4698. PubMed ID: 27680873
[Abstract] [Full Text] [Related]
16. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009 Dec 01; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
17. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
Bey-Omar F, Feit JP, Forest MG, David M.
Pediatrie; 1983 Mar 01; 38(2):77-86. PubMed ID: 6622141
[Abstract] [Full Text] [Related]
18. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
J Clin Endocrinol Metab; 1995 Jul 01; 80(7):2238-43. PubMed ID: 7608286
[Abstract] [Full Text] [Related]
19. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
Horm Res; 2008 Jul 01; 70(1):42-50. PubMed ID: 18493149
[Abstract] [Full Text] [Related]
20. Course of COVID-19 infection in patients with congenital adrenal hyperplasia.
Javaid R, Sinaii N, Kollender S, Desai J, Moon A, Merke DP.
Front Endocrinol (Lausanne); 2024 Jul 01; 15():1348130. PubMed ID: 38405151
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
